








































































(1).	 This	 is	 particularly	 relevant	 during	 DNA	
replication	as	highlighted	by	the	overrepresen-
tation	 of	 replication-associated	 spontaneous	
mutations	in	cancer	(2).	In	a	constantly	chang-
ing	environment,	 cell	 survival	 requires	a	 fine-
tuned	 control	of	 replication.	 Since	DNA	 repli-
cation	 in	eukaryotic	 cells	 initiates	 from	multi-
ple	 replication	 origins,	 it	 can	 be	 regulated	 at	
both	the	frequency	of	origin	initiation	and	the	
rate	 of	 replication	 fork	 progression.	 The	 in	
vitro	 reconstitution	 of	 the	 eukaryotic	 repli-
some	 with	 purified	 proteins	 has	 recently	
boosted	 our	 knowledge	 of	 both	 processes	 in	
eukaryotes	(3,	4).	However,	we	still	 lack	a	full	








Somyajit	 et	 al.	 report	 that	 forks	 slowed	
down	 in	 human	 cells	 treated	 with	 low	 dose	
hydroxyurea	 (HU),	an	 inhibitor	of	 the	 ribonu-
cleotide	 reductase	 (RNR).	 RNR	 is	 an	 essential	
enzyme	 in	 all	 living	 organisms	 that	 catalyses	
the	 production	 of	 deoxyribonucleotide	 tri-
phosphates	 (dNTPs),	 the	 components	 that	
make	 up	 DNA.	 Low	 levels	 and	 imbalanced	
dNTPs	challenge	genome	integrity	by	inducing	
replication	fork	stalling	and	DNA	breaks	as	well	
as	mutagenesis	 due	 to	 the	unequal	 competi-
tion	 between	 the	 dNTPs.	 Instead,	 high	 dNTP	
levels	can	impair	the	polymerase	proofreading	
activity	or	promote	polymerase	slippage,	also	
leading	 to	 mutagenesis.	 Hence,	 dNTP	 pool	
changes	 can	promote	 tumorigenesis,	 framing	
RNR	 as	 an	 important	 target	 for	 anti-cancer	
drugs	 (6).	 At	 high	 doses,	 HU	 induces	 replica-
tion	 fork	stalling	and	activates	 the	DNA	dam-
age	 checkpoint	 with	 dramatic	 consequences	
on	origin	firing.	These	include	the	global	inhibi-
tion	of	 new	origin	 firing	 and	 the	 local	 activa-
tion	of	the	so-called	‘dormant’	origins to	ena-
ble	 full	 chromosome	 duplication	 while	
preventing	further	replication	fork	stalling	(7).	




of	HU,	 insufficient	 to	 stall	 replication	 forks	or	
activate	 the	 DNA	 damage	 checkpoint,	 was	
able	to	modulate	replication	fork	speed	direct-
ly,	 rapidly,	and	 independently	of	dNTP	 levels.	
This	occurs	by	 the	 reaction	catalysed	by	RNR	
itself.	 RNR	 converts	 ribonucleoside	 5’-
diphosphates	 (NDPs)	 into	 2’-
deoxyribonucleoside	 5’-diphosphates	(dNDPs)	
via	an	electron	transfer	that	when	inhibited	by	
HU	 causes	 a	 redox	 imbalance.	 The	 observed	
replication	 fork	 slow	 down	 correlated	with	 a	
rapid	dissociation	of	different	 components	of	
the	 replication	 protection	 complex,	 such	 as	
TIMELESS	 and	 TIPIN,	 from	 replication	 forks.	
Consistently,	 several	 studies	 with	 the	 yeast	







dNTP	precursors,	a	 result	 that	 could	be	 reca-
pitulated	 with	 H2O2	 (5)	 undoubtedly	 arguing	




lism	 and	 include	 hydrogen	 peroxide	 (H2O2),	
superoxide	 (O2−)	 and	 hydroxyl	 radicals	 (OH−).	







ing	 is	 mediated	 by	 the	 interaction	 between	
TIMELESS	 and	 one	 component	 of	 this	 redox	
signaling	 response,	 peroxiredoxin	 2	 (PRDX2).	
This	is	an	antioxidant	enzyme	from	the	perox-
iredoxin	 family,	 which	 are	 highly	 sensitive	 to	
subtle	 fluctuations	 in	 ROS	 levels.	 Somyajit	 et	
al.	propose	that	oxidation	of	PRDX2	oligomers,	
which	occur	on	exposure	to	ROS,	induces	their	
disruption	 and	 dissociation	 from	 chromatin,	
dragging	 out	 TIMELESS-TIPIN	 from	 ongoing	
replisomes	and	thus	slowing	down	replication	
fork	 progression	 in	 an	 oxidizing	 environment	
(see	the	figure).		
Failures	 in	 this	coupling	mechanism	(as	 in	
PRDX2-deficient	 cells)	 lead	 to	 replication-
dependent	 and	 TIMELESS-mediated	 genetic	
instability,	as	observed	by	the	increased	occur-
rence	 of	 DNA	 lesions	 typically	 derived	 from	
replicative	 stress,	 such	 as	 ultrafine	 anaphase	
DNA	 bridges	 and	 p53	 binding	 protein	 1	
(53BP1)	 nuclear	 bodies	 (5).	 The	 concept	 of	
replicative	stress	may	thus	need	to	be	revisit-
ed	 beyond	 replication	 fork	 slowdown	 and/or	
stalling	to	include	also	replication	acceleration.	
This	indicates	that	the	PRDX2-TIMELESS	inter-
action	 prevents	 the	 damaging	 consequences	
to	 DNA	 of	 metabolite	 oscillations.	 Notably,	
cancer	cells	show	high	levels	of	ROS,	slow	rep-
lication	forks	and	are	highly	sensitive	to	PRDX2	
inactivation,	 implying	 that	 they	 exploit	 this	
coupling	mechanism	 to	 allow	 tumor	 cell	 sur-
vival	(5).	The	necessity	of	this	pathway	for	tu-






prevent	 the	 negative	 consequences	 of	 oxida-
tive	stress	on	replication	in	strictly	aerobic	eu-
karyotic	 cells,	 whereas	 anaerobic	 facultative	
cells	 like	yeast	can	 temporarily	 separate	DNA	
synthesis	 from	 ROS-generating	 respiration	
processes	(13).	Since	cancer	cells	use	this	cou-
pling	 mechanism	 to	 bypass	 their	 abnormally	




pacts	 on	 DNA	 repair	 insufficiency-associated	
manifestations	such	as	premature	ageing	and	
genetic	 diseases	 (14)	 and	 at	 vulnerable	 DNA	
regions	such	as	telomeres	or	sites	of	transcrip-
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genome,	 the	 presence	 of	 TIMELESS-TIPIN	 at	 the	
replisome	 speed	up	 replication.	However,	 in	 the	
presence	of	subtle	changes	in	ROS,	peroxiredoxin	
PRDX2	oligomers	are	oxidized	and	disrupted,	thus	
being	 dissociated	 from	 chromatin.	 The	 interac-
tion	 between	 PRDX2	 and	 TIMELESS	 causes	
TIMELESS-TIPIN	 dissociation	 from	 ongoing	 repli-
somes,	 so	 forks	 slow	 down	 as	 a	 mechanism	 to	
safeguard	genome	integrity.	Cancer	cells,	with	an	
abnormally	 high	 oxidative	 stress	 derived	 from	
their	altered	metabolism,	use	 this	mechanism	of	
fork	slow	down	for	survival.	
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